通过PRMT1介导的代谢重编程促进了白血病发生
Hairui Su1, Yong Sun2,3, Han Guo4
1Department of Biochemistry and Molecular Genetics, The University of Alabama at Birmingham, School of Medicine, Birmingham, United States.
eLife
|August 13, 2025
概括
蛋白质氨酸甲基转移酶1 (PRMT1) 驱动急性巨核细胞白血病 (AMKL) 通过促进糖解和阻碍脂肪酸氧化. 抑制PRMT1或准葡萄糖代谢为这种癌症提供了治疗策略.
科学领域:
- 在瘤学瘤学.
- 癌症新陈代谢 癌症新陈代谢
- 分子生物学分子生物学
背景情况:
- 蛋白质氨酸甲基转移酶1 (PRMT1) 在癌症中经常过度表达,与患者生存率差相关.
- 急性巨核细胞白血病 (AMKL) 是急性髓性白血病的一个亚型,具有特定的分子驱动因素.
- 白血病细胞系内PRMT1表达的异质性表明,不同的亚种群可能会推动疾病的进展.
研究的目的:
- 研究PRMT1在AMKL病变发生中的作用及其对细胞代谢的影响.
- 在临床前AMKL模型中评估PRMT1抑制的治疗潜力.
- 阐明PRMT1在白血病细胞中调节的代谢途径.
主要方法:
- 使用了一种具有异质Prmt1表达的小鼠AMKL细胞系 (6133).
- 使用PRMT1抑制剂 (MS023) 进行治疗干预.
- 进行海马分析以评估细胞呼吸和糖解.
- 进行了代谢和流动细胞计分析,以评估脂质代谢.
- 给了2-deoxy-D-glucose并进行了基因救援实验.
主要成果:
- 在AMKL细胞亚群中高PRMT1表达对于体内白血病的发展至关重要.
- 通过MS023有效治疗PRMT1驱动的AMKL来抑制PRMT1.
- PRMT1上调糖解 (增加细胞外酸化率,葡萄糖消耗,乳酸生产) 和下调脂肪酸氧化 (减少氧气消耗率,减少CPT1A表达).
- PRMT1促进了细胞内脂质的积累.
- 葡萄糖模拟治疗延迟了AMKL的进展并诱导了分化;Cpt1a再表达挽救了扩散.
结论:
- 通过增强糖解和抑制脂肪酸氧化,PRMT1促进AMKL的扩散.
- 向PRMT1或葡萄糖代谢是AMKL的一个有前途的治疗策略.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K


